Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05219695 · ClinicalTrials.gov registry record · NA

Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)

A NA study of Breast Cancer Stage I and Fibroadenoma, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT05219695 is a NA study of Breast Cancer Stage I and Fibroadenoma that is actively recruiting participants, run by Columbia University. The registered enrollment target is 36 participants, below the 164-participant average among 18 other Breast Cancer Stage I trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05219695, a NA study of Breast Cancer Stage I and Fibroadenoma, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to demonstrate the initial clinical feasibility of using Harmonic Motion Imaging (HMI) for Focused Ultrasound Surgery (FUS) guidance and monitoring in patients with benign and stage 1 non-metastatic breast cancers. The investigators hypothesize that changes in HMI parameters will inform progression of FUS ablation.

Interventions

  • PROCEDURE Harmonic motion imaging guided focused ultrasound (HMIgFUS)

Study Locations (1)

New York

  • Columbia University Irving Medical Center/NYP - New York

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2022-01-19
Est. Completion 2026-05
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05219695

The ClinicalTrials.gov registry entry for NCT05219695 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 18 other Breast Cancer Stage I trials with a reported enrollment target (78% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer Stage I appearing as the primary indexed condition, and to 1 intervention - of which Harmonic motion imaging guided focused ultrasound (HMIgFUS) is the first listed.

NCT05219695 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05219695 about?

NCT05219695 is a clinical study titled "Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)". The objective of this study is to demonstrate the initial clinical feasibility of using Harmonic Motion Imaging (HMI) for Focused Ultrasound Surgery (FUS) guidance and monitoring in patients with benign and stage 1 non-metastatic breast cancers. The investigators hypothesize that changes in HMI para...

What is the current status of trial NCT05219695?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2022-01-19. Estimated completion is 2026-05.

What conditions does trial NCT05219695 study?

This clinical trial studies the following conditions: Breast Cancer Stage I, Fibroadenoma.

What interventions are being tested in trial NCT05219695?

The interventions under investigation include: Harmonic motion imaging guided focused ultrasound (HMIgFUS) (PROCEDURE).

Who is sponsoring clinical trial NCT05219695?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05219695 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer Stage I

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.